Privacy Policy
This Privacy Policy establishes the terms on which WebCim uses and protects the information that is provided by its users when using your website. This company is committed to the security of its users' data. When we ask you to fill in the fields of personal information, such as email, with which you can be identified, we do so by ensuring that it will only be used in accordance with the terms of this document. However, this Privacy Policy may change over time or be updated for what we recommend and we strongly encourage you to continually review this page to ensure that you agree to such changes.
Information that is collected
Our website may collect personal information, for example: email.
Use of the information collected
Our website uses the information in order to provide the best possible service, particularly to maintain a user registry. It is possible that periodic emails are sent through our site with a summary of news and events, these emails will be sent to the address you provide and may be canceled at any time. WebCim is highly committed to fulfill the commitment to keep your information secure.
Links to Third Parties
This website may contain links to other sites that may be of interest to you. Once you click on these links and leave our site, we no longer have control over the site to which you are redirected and therefore we are not responsible for the terms or privacy or the protection of your data in those other third party sites. These sites are subject to their own privacy policies, so it is recommended that you consult them to confirm that you agree with them.
Control of your personal information
Each time you are asked to fill in a form, such as the news and event comments, you must complete the requested captcha. WebCim reserves the right to change the terms of this Privacy Policy at any time.
Frequent Questions
How can I access the therapeutic vaccines against lung cancer?
Cuba has 2 therapeutic vaccines for advanced lung cancer: CIMAvax EGF ® and VAXIRA ® (racotumomab). Both therapeutic vaccines have sanitary registration in the indication of stage III and IV advanced non-small cell lung cancer (NSCLC), after the first line of chemotherapy. The main clinical benefit of these vaccines has been shown to be increased survival and improved quality of life, as well as a broad safety profile. How to acquire the vaccines? Foreigners should contact the Cuban Medical Services who will evaluate each case as part of a comprehensive patient care program, with commercial value. -Cuban Medical Services. Web page: www.smcsalud.cu.; E-mail: smc@smcsalud.cu Phone: (537) 209-0977 Fax: (537) 203-1590. You can also make your request for care expressing the reason for your request, a medical summary and personal data directly to: International Clinic of the Hermanos Ameijeiras Hospital. Calle San Lázaro # 701 esq. to Belascoaín, Havana Center, Havana, C.P: 10400, Cuba. Telephone: (537) 8761029, (537) 8761030, (537) 8761683. Email: turismomedico@hha.sld.cu International Health Center La Pradera Calle 15 between 222 A and 234, Siboney neighborhood, Playa Municipality, Havana, Cuba Telephone: (+537) 273 7467 Ext. 403 (+537) 2737202. Email: comercia@cislapradera.cu